Drug use Pattern and Antenatal Care Utilization Among Pregnant Women in Ethiopia
Abstract Background: Taking medications during pregnancy can harm both the mother and fetus. However, avoiding drug utilization is a difficult due chance to occur maternal complications. The irrational use of medicine remains to worsen in developing countries. The main objective of this study was to evaluate the medication use pattern and its determinants among pregnant women in Ethiopia. Methods: This study used the national representative secondary data obtained from the 2016 Ethiopian Demographic health survey (DHSprogram.com/Data). Simple descriptive statistics were used to present the socio-economic characteristics of the respondents. Bivariate and multivariate regression models were performed consecutively to examine the significant statistical association between medication use and independent variables. Variables p < 0.25 during bivariate analysis were further analyzed with a multivariate regression model. A significant statistical association was detected if p < 0.05 at 95% confidence interval (CI). The 95% CIs and Odds ratios (OR) were also calculated for significant variables in bivariate regression. Stata/SE 14.2 statistical software was used to analyze the data.Results: About 10,29 (91.8%) of surveyed pregnant had taken at least one prescription drug. Thus, supplementary drugs were dominant (34% of iron folate). The prevalence of non supplementary drugs such as anthelmintic (15.3%), antibiotics (6%) followed by antimalarial (1.7%) drugs. Less than half 380 (34%) pregnant had received antenatal care (ANC) during their pregnancy. Thus, the majority of 364 (96%) of them received the ANC service at public health sectors. Most pregnant were in the second trimester when they started ANC. Pregnant aged from 35-49 years used drugs less likely by 65% (OR = 0.35, 95% CI =0.069-1.772) compared to younger pregnant. Poorer mothers were more likely to take medications by 53% (OR=0.47, 95% CI = 0.218-1.628) than middle income. The majority of pregnant were used medication during the second trimester (39.3%) followed by the third trimester (38.5%). Conclusion: The utilization of ANC was lower among pregnant women. Hence, increasing the coverage and utilization of ANC services is needed to improve the consumption of supplements and other preventive chemotherapy. Likewise, to expand the ANC service channel is important to monitor the irrational drug use of pregnant.